Real-World Evidence of Temporal Variation in PD-L1 Expression

被引：0
|
作者：
Sudarsanam, Sucha [1 ]
Hatooglu, Medina [1 ]
O'Malley, Dennis [2 ]
Weiss, Lawrence [3 ]
机构：
[1] NeoGen Labs Inc, Aliso Viejo, CA USA
[2] NeoGen Labs Inc, Dana Point, CA USA
[3] NeoGen Labs Inc, Pasadena, CA USA
来源：
MODERN PATHOLOGY | 2020年 / 33卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1830
引用
收藏
页码：1713 / 1714
页数：2
相关论文
共 50 条
  • [1] Real-World Evidence of Temporal Variation in PD-L1 Expression
    Sudarsanam, Sucha
    Hatooglu, Medina
    O'Malley, Dennis
    Weiss, Lawrence
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1713 - 1714
  • [2] Real-World PD-L1 Expression in Lung Cancer and its Correlation with Driver Mutations
    Wang, T.
    Xiao, S.
    Zhao, L.
    Chai, T.
    Fang, X.
    Lin, R.
    Li, T.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S452 - S452
  • [3] Beyond PACIFIC: Real-World Outcomes of Adjuvant Durvalumab According to Treatment Received and PD-L1 Expression
    Denault, Marie-Helene
    Feng, Jamie
    Kuang, Shelley
    Shokoohi, Aria
    Leung, Bonnie
    Liu, Mitchell
    Berthelet, Eric
    Laskin, Janessa
    Sun, Sophie
    Zhang, Tina
    Ho, Cheryl
    Melosky, Barbara
    CURRENT ONCOLOGY, 2023, 30 (08) : 7499 - 7507
  • [4] Beyond PACIFIC: Real-world outcomes of adjuvant durvalumab according to treatment received and PD-L1 expression
    Denault, M-H.
    Feng, J.
    Kuang, S.
    Shokoohi, A.
    Leung, B.
    Liu, M.
    Berthelet, E.
    Laskin, J.
    Sun, S.
    Zhang, T.
    Ho, C.
    Melosky, B.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S986 - S986
  • [5] Real-world adoption of PD-L1 testing in metastatic urothelial carcinoma.
    Gupta, Shilpa
    Maculaitis, Martine C.
    Bernstein, Andrew
    Boudoures, Anna
    Tesic-Schnell, Marija
    Seal, Brian S.
    Mulvihill, Emily
    Doleh, Yunes
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] Analysis of real-world PD-L1 testing in patients with urothelial carcinoma.
    Krigsfeld, Gabriel S.
    Prince, Emily
    Zerba, Kim
    Chizhevsky, Vladislav
    Ragheb, Josette William
    Novotny, James
    White, James William
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [7] Prevalence of PD-L1 Expression in Non-Small Cell Lung Cancer: a Real-World Australian Perspective
    Prabhakaran, S.
    Russell, P. A.
    Farrall, A. L.
    Asadi, K.
    Barrett, W.
    Cooper, C.
    Cooper, W.
    Duhig, E. E.
    Egan, M.
    Fox, S.
    Godbolt, D.
    Gupta, S.
    Cotton, S.
    Leslie, C.
    Leong, T.
    Moffat, D.
    Qiu, M.
    Sivasubramaniam, V.
    Snell, C.
    Skerman, J.
    Walsh, M.
    Whale, K.
    Klebe, S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S479 - S479
  • [8] Real-World Effectiveness of Nivolumab by PD-L1 Expression in NSCLC pts in Japan: A Multicenter-Retrospective Study
    Kim, Young Hak
    Morita, Ryo
    Okishio, Kyoichi
    Simizu, Junichi
    Saito, Haruhiro
    Sakai, Hiroshi
    Hataji, Osamu
    Yomota, Makiko
    Nishio, Makoto
    Aoe, Keisuke
    Kanai, Osamu
    Kumagai, Toru
    Kibata, Kayoko
    Tsukamoto, Hiroaki
    Oizumi, Satoshi
    Tomii, Keisuke
    Tanaka, Hiroshi
    Mizuno, Keiko
    Hoshiyama, Hirotoshi
    Ochi, Kenya
    Ohe, Yuichiro
    ANNALS OF ONCOLOGY, 2019, 30
  • [9] PD-L1 expression and its significance in advanced NSCLC: real-world experience from a tertiary care center
    Kilaru, Sindhu
    Panda, Soumya Surath
    Moharana, Lalatendu
    Mohapatra, Debahuti
    Mohapatra, Satya Sundar G.
    Panda, Adyakinkar
    Kolluri, Spoorthy
    Devaraj, Suma
    Biswas, Ghanashyam
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2024, 36 (01)
  • [10] PD-L1 expression and its significance in advanced NSCLC: real-world experience from a tertiary care center
    Sindhu Kilaru
    Soumya Surath Panda
    Lalatendu Moharana
    Debahuti Mohapatra
    Satya Sundar G. Mohapatra
    Adyakinkar Panda
    Spoorthy Kolluri
    Suma Devaraj
    Ghanashyam Biswas
    Journal of the Egyptian National Cancer Institute, 36
12345